Ad
related to: concord biotech annual report- Annual B2B Data Report
Adapt In The Face Of Uncertainty.
Survive Today's Business Landscape.
- 200 Free Leads
Target Key Decision-Makers Now.
Get 200 Customized, Targeted Leads.
- B2B Marketing Report
Is Data Driving or Derailing
Your Sales & Marketing Strategy?
- Free ABM eBook
Leverage A Strong Data
Foundation. Fuel ABM Success.
- Annual B2B Data Report
Search results
Results From The WOW.Com Content Network
Concord Biotech was founded in 2000 by Sudhir Vaid, a former director at Ranbaxy Laboratories. [4] It was the first company in India and the second in the world to develop an anti-immuno suppressant tacrolimus. [7] In 2004, Rakesh Jhunjhunwala acquired around 14% stake in the company.
Nimmagadda acquired Medicorp Technologies in May 2003, Vorin Labs in September 2003, Vera Laboratories, Fine Drugs & Chemicals the same year 2004 and a controlling stake in Concord Biotech in 2006. Nimmagadda set his eyes on the global pharma-scape by acquiring Belgium-based Docpharma in June 2005, and a controlling stake in China's McChem Group .
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., and PARIS, Jan. 12, 2025 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, and Orano Med, a clinical-stage ...
REHOVOT, Israel, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that overcome tumor immune evasion and drug resistance, today announced financial results for the three and nine months ended September 30, 2024.
In the United States, a more-detailed version of the report, called a Form 10-K, is submitted to the U.S. Securities and Exchange Commission. [2] A publicly held company may also issue a much more limited version of an annual report, which is known as a "wrap report." A wrap report is a Form 10-K with an annual report cover wrapped around it. [3]
Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry.
Jennifer and Brandon Sheffield were found dead by gunshot wounds in an apparent murder-suicide by police in Mississippi on Dec. 28, according to reports Woman Praised ‘Incredible’ Ex-Husband ...